A New Neurotech Startup Launches to Rival Sam Altman’s Merge Labs

What happened

A new venture called Bridge Neurotech has launched with plans to build a wearable, non-invasive brain-computer interface based on ultrasound technology, positioning itself as a direct competitor to Merge Labs, the brain-computer interface startup co-founded by OpenAI chief executive Sam Altman, according to Wired.

Unlike implant-based approaches such as Neuralink, which require surgery to place electrodes inside the skull, Bridge Neurotech's device is designed to be worn externally, using ultrasound to read or interact with brain activity. The move adds a third high-profile entrant to a brain-computer interface field increasingly shaped by technologists with deep ties to the AI industry.

Why it matters

Brain-computer interfaces have mostly been framed around invasive, clinical use cases — restoring movement or speech for people with severe disabilities. A credible, non-invasive, wearable alternative changes the calculus: it lowers the barrier to adoption from "requires neurosurgery" to "requires putting on a headset," which opens the door to broader commercial, enterprise and consumer applications long before any implant could scale.

The entry of a second major player alongside Merge Labs also signals that well-capitalised figures from the AI world now see brain-interface hardware as a plausible extension of AI itself — a new input layer sitting alongside voice, text and vision. For technology and transformation leaders, this is an early signal worth tracking rather than an immediate operational concern: the direction of travel suggests neural data could eventually become another channel organisations have to think about collecting, securing and designing experiences around.

The Renascence take

It is easy to read this as simply another skirmish in the AI arms race. The more interesting story is about trust architecture: wearable neurotech asks people to voluntarily expose arguably the most intimate data stream there is — brain activity — before any clear consumer use case, regulatory framework or security track record exists.

Hardware races are won on engineering; adoption races are won on trust. The organisations building wearable brain interfaces will ultimately be judged less on signal fidelity than on whether they can make an inherently unsettling proposition feel safe, consensual and genuinely useful in everyday moments. Anyone exploring this space — or adjacent biometric and sensor-driven experiences — should be designing the consent, transparency and opt-out journey with the same rigour as the ultrasound hardware itself, because the first wearable BCI to lose public trust will set the tone for every competitor that follows.